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To the Editor:
The National Health and Nutrition Examination Survey (NHANES) has tested for 
Mycobacterium tuberculosis infection three times: in 1971–1972, 1999–2000, and 2011–
2012. Based on tuberculin skin test results, the estimated national prevalence of latent 
tuberculosis infection (LTBI) among adults was 11%–18% in 1971–1972 but has remained 
≤6% in subsequent NHANES cycles (1–4). A single 2-year NHANES cycle is designed to 
produce accurate and stable estimates for conditions of ≥10% prevalence in the 
noninstitutionalized civilian U.S. population (5–7), suggesting that NHANES might no 
longer be as nationally representative for LTBI as it is for more common health conditions. 
Approximately 30 counties were selected for each 2-year cycle (5). We wished to examine 
whether persons in selected counties might have been systematically more or less likely to 
have a positive tuberculin skin test than their counterparts in the approximately 3,100 
counties that were not selected for NHANES participation.
Methods
We created a non-NHANES dataset with demographic profiles and tuberculosis data for all 
3,143 U.S. county equivalents (Table 1). The U.S. Census Bureau and Department of 
Agriculture websites provided each county’s population size and racial/ethnic composition, 
rural vs. urban classification, and poverty prevalence for 1970 through 2013. The National 
Tuberculosis Surveillance System provided annual tuberculosis disease incidence, with the 
U.S. Census Bureau’s Current Population Survey providing county population 
denominators.
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We also used genotyping results to derive an estimate of longstanding LTBI prevalence for 
each county. Briefly, this simple back-calculation method assumed that TB cases not 
attributed to recent transmission (i.e., based on genotyping results) instead arose from 
preexisting LTBI. Then a 0.1% annual risk of reactivation was used to derive an estimated 
number of county residents with untreated LTBI (8). This county-level LTBI estimation 
method has not been validated; the only potential comparison in the literature is based on 
1958‒1965 data (9). However, median estimated LTBI prevalence among the U.S.-born was 
0.7% (lower and upper quartiles: 0.4%, 1.3%) and among the non-U.S.-born was 13.1% 
(lower and upper quartiles: 8.8%, 18.5%), both of which were similar to previous national 
NHANES-based estimates (1, 3, 4).
Because of disclosure risk, county of residence is not included in the NHANES public-use 
datasets and cannot be released (10). Following Research Data Center procedures (https://
www.cdc.gov/rdc/), the National Center for Health Statistics merged masked NHANES 
1971–1972, 1999–2000, and 2011–2012 data with our non-NHANES county dataset and 
allowed us to conduct this geographic analysis without access to county identifiers.
Results
The demographics of the counties selected for NHANES participation in 1971–1972, 1999–
2000, and 2011–2012 were similar across time, except that the counties selected for 
NHANES 2011–2012 had higher proportions of residents living in poverty, consistent with 
the recent national trend (Table 1). We compared the selected to nonselected counties within 
strata of counties of similar population size, racial/ethnic composition, rural vs. urban 
classification, and poverty prevalence. Within those strata, mean tuberculosis disease 
incidence and estimated LTBI prevalence were similar (P > 0.05 for each test of equivalence) 
when comparing the selected to the nonselected counties in NHANES 1971–1972, 1999–
2000, and 2011–2012. In 90% of the counties selected for NHANES 2011–2012, the 
unweighted prevalence of a tuberculin skin test result of ≥10 mm of induration was within 
1% of the genotyping-derived LTBI prevalence estimate for that county (8).
Discussion
Because of strict confidentially protections that include the geographic locations of 
NHANES participants, the results of this masked analysis cannot be shown in more detail 
(10). However, our findings reinforce confidence in national LTBI prevalence estimates 
based on past NHANES cycles (1–4). We found no evidence that the selected counties had 
different tuberculosis disease incidence or different LTBI prevalence from the counties not 
selected for NHANES participation in 1971–1972, 1999–2000, and 2011–2012.
Despite these reassuring findings, both the low prevalence and geographic heterogeneity of 
this condition in the United States suggest that incorporating tuberculosis components (e.g., 
interferon-gamma release assays) into future NHANES cycles for >2 consecutive years 
would help achieve more stable population estimates (4–7). Our findings also imply that 
genotyping-derived estimates of county-level LTBI prevalence that do not rely on NHANES 
data could continue to prove useful in the future (8).
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Table 1.
Demographic characteristics pertinent to tuberculosis burden, and active tuberculosis disease incidence, by 
county or county equivalent*, during the 1971–1972, 1999–2000, and 2011–2012 National Health and 
Nutrition Examination Survey (NHANES) cycles (N=3,143 counties)
No. counties (percent)
1971–1972 1999–2000 2011–2012
County size
 ≤10,000 population at time of NHANES cycle 876 (28) 697 (22) 698 (22)
 10,001–24,999 1,016 (32) 886 (28) 845 (27)
 25,000–99,999 902 (29) 1,036 (33) 1,022 (33)
 ≥100,000 349 (11) 524 (17) 578 (18)
Non-U.S.-born population†
 <2% of county’s total population † 1,702 (54) 1,683 (54)
 2.0%–4.9% of county’s total population 832 (26) 788 (25)
 5.0%–9.9% of county’s total population 376 (12) 410 (13)
 ≥10% of county’s total population 233 (7) 262 (8)
Metropolitan/urban‡ 2,495 (79)‡ 2,053 (65) 1,976 (63)
Nonmetropolitan/rural‡ 648 (21)‡ 1,090 (35) 1,167 (37)
Poverty level
 <10% of population in poverty 322 (10)§ 851 (27) 310 (9)
 10%–15.5% in poverty 1,407 (45)§ 1,362 (43) 1,092 (35)
 15.6%–19.9% in poverty 518 (16)§ 558 (17) 825 (26)
 ≥20% in poverty 896 (29)§ 372 (12) 916 (29)
Historic tuberculosis disease incidence (1963–1972)
based on state’s total population§
 Low (in state averaging <15 annual cases per 100,000) 631 (20) — —
 Medium (15–20 cases per 100,000) 488 (16) — —
 High (≥20 cases per 100,000) 2,024 (64) — —
Recent tuberculosis disease incidence (1996–2003)
among county’s U.S.-born population
 None (county with 0 cases among U.S.-born) — 622 (20) —
 Low/Medium (averaging <10 annual cases per 100,000) — 2,339 (74) —
 High (county with ≥10 annual cases per 100,000) — 182 (6) —
among county’s non-U.S.-born population†
 None (county with 0 cases among non-U.S.-born) — 1,641 (52) —
 Low/Medium (averaging <10 annual cases per 100,000) — 173 (6) —
 High (county with ≥10 annual cases per 100,000) — 1,329 (42) —
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No. counties (percent)
1971–1972 1999–2000 2011–2012
Modern tuberculosis disease incidence (2008–2015)
among county’s U.S.-born population
 None (county with 0 cases among U.S.-born) — — 1,041 (33)
 Low/Medium (averaging <10 annual cases per 100,000) — — 2,076 (66)
 High (county with ≥10 annual cases per 100,000) — — 26 (1)
among county’s non-U.S.-born population† — —
 None (county with 0 cases among non-U.S.-born) — — 1,607 (51)
 Low/Medium (averaging <10 annual cases per 100,000) — — 275 (9)
 High (county with ≥10 annual cases per 100,000) — — 1,261 (40)
*
Included as county equivalents are the Alaska boroughs, the District of Columbia, Louisiana parishes, and Virginia independent cities
†Where the county’s non-U.S.-born proportion was provided by the U.S. Census Bureau’s Current Population Survey, that proportion was applied 
to the total county population size to derive a non-U.S.-born count. In 2000, the Current Population Survey provided an estimate of the proportion 
of the county’s population that was non-U.S.-born; in later years, that proportion is only consistently available at the state level. In 2010, it was 
provided for 801 counties only; for the other 2,342 counties, the non-U.S.-born population size was imputed based on the county’s non-U.S.-born 
proportion in 2000 and the state’s total non-U.S.-born population size in 2010.
‡
Rural-Urban Continuum Codes from the U.S. Department of Agriculture for 1974, 2003, and 2013 were dichotomized into these two categories 
(i.e., codes 4–9 considered rural and codes 0–3 considered metropolitan). Note that due to changes to the criteria that were implemented after the 
2000 Census, the 1974 Rural-Urban Continuum Codes are not directly comparable with those in 2003 and 2013.
§
Measures of poverty in 1970 and TB disease incidence in 1963–1972 only available at the state level; later measures from the National 
Tuberculosis Surveillance System are at the county level.
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